PerCP/Cyanine5.5 anti-human CD8 [SK1] and 3 more items

The University of Virginia awarded contract A207_PO-0457070 to BioLegend Inc. on July 10, 2026, for the procurement of specialized laboratory reagents and diagnostic antibodies. The contract, valued at $846, encompasses four distinct line items totaling research-grade flow cytometry reagents for immunological analysis. The materials are designated for delivery to Selin Ustel and include PerCP/Cyanine5.5 anti-human CD8 [SK1] at $255.50, Brilliant Violet 711 anti-T-bet [4B10] at $181.50 (two units), and PE anti-human CD4 [RPA-T4] at $227.50.

These antibody conjugates serve as critical tools for cellular immunophenotyping and T-cell subset characterization in research applications. The supplies support the University of Virginia's scientific research capabilities in Virginia and are intended for use in flow cytometry-based assays examining lymphocyte populations and transcription factor expression. The award represents a small-value purchase order for specialized life science materials essential to immunological research conducted within the University's research infrastructure.